Health Condition 1: K029- Dental caries, unspecified
Conditions
Interventions
Intervention1: Oxirinse Dispersible tablet: Dose: 20 ml,
Route of administration: Oral, Frequency: Once a day
Total duration of therapy: 1 Day
Control Intervention1: Listerine Mouthwash: Dose: 20 ml,
Sponsors
Avance Phytotherapies Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Willing to participate by providing written informed consent 2. Patients with high caries risk 3. Good general health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history or oral/ dental examination. 4. Patient having at least 12 gradable teeth. 5. Patient in agreement to delay any elective dental treatment including oral prophylaxis 6. Is the patient having ability to understand and consent to participate in this clinical study, expressed by signing the consent form? 7. Patient ready to comply with the study visits were included in the study
Exclusion criteria
Exclusion criteria: 1. History of systemic diseases 2. History of oral prophylaxis within 6 months previous to the study 3. Known or suspected intolerance or hypersensitivity to Chlorhexidine or other study materials (or closely related compounds) or any of their stated ingredients. 4. Patient with mouth breathing habit 5. Patient using orthodontic and prosthodontic appliances
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Salivary pH Salivary buffer capacity Microbial count of saliva Timepoint: Visit1 day1 visit2 day3 | — |
Secondary
| Measure | Time frame |
|---|---|
| Dysgeusia Transient burning/stinging of mucous membrane secondary to mouth rinse Timepoint: Visit1 day1 visit2 day3 | — |
Countries
India
Contacts
Public ContactDr Suvodip Shaw
iDD Research Solution INC
Outcome results
None listed